Clinical Trial Update: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating LBP-EC01 for acute uncomplicated urinary tract infection caused by drug-resistant E. coli; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Urinary Tract Infection

Drugs mentioned

• LBP-EC01

Snippet

Sponsor: Locus Biosciences | Conditions: Urinary Tract Infections | Phase 2 | Status: RECRUITING